| In € million | 2008 | 2009 | Change | Change in constant dollars |
| First quarter | 24.0 | 27.5 | + 14.8 % | + 5.2 % |
| Average US dollar exchange rate | 1.4932 | 1.3020 |
Naturex posted revenues of € 27.5 million in the first quarter of 2009, up 14.8% on the previous year. In constant dollars, growth amounted to +5.2% in line with Group forecasts for the year.
Broken down by market, the Group’s Nutrition & Health business arm accounted for 64.6% of quarterly revenues (vs. 60.9% in Q1 2008), Food & Beverage for 28.9% (vs. 33.7%) and Personal Care for 1.4% (vs. 2.5%). 61.0% of quarterly revenues were generated in the United States (vs. 56.6% in Q1 2008), 30.1% in the European Union (vs. 35.7%) and 2.6% in Asia (vs. 3.5%).
Highlights
Despite the unsettled market climate, Naturex’s capital increase of € 17.3 million in February was a success and will provide the Group with the means to pursue its future growth.
This growth dynamic will also be accompanied by Naturex’s new visual identity designed to reflect the Group’s solid position and new structure according to market sector.
Outlook
In light of its performance in the first quarter, Naturex Group has confirmed its targets of growth of between 5 and 10% in revenues (like-for-like and in constant dollars) and a new increase in operating margin in 2009.
Naturex will hold its Annual General Meeting on June 30 and will publish its revenues for the first half of 2009 on July 21 after the close of the markets.
Contacts:
Thierry Lambert – Vice-President and CFO
t.lambert@naturex.com
Tel.: +33 (0)4 90 23 96 89
Laurence Marquézy, Actus
Tel.: +33 (0)1 72 74 82 23
lmarquezy@actus.fr
NATUREX has been listed on segment C of Euronext Paris since October 1996.
ISIN FR0000054694 – Reuters NATU.LN – Bloomberg NTRX.
29/04/2009